Contact UCHealth
Contact UCHealth
Clinical Trials
Make a Gift
Vulvar cancer is a cancer that starts in the vulva, the outer portion of the female genitals. The vulva includes the vaginal opening, the labia, and the clitoris.
Vulvar cancer prognosis depends on the type of cancer and the stage at which it is diagnosed.
Vulvar cancer is rare, accounting for 0.7% of all cancers in women and around 6% of all cancers of the female reproductive organs. The American Cancer Society estimates that in a given year, around 6,900 new cases of vulvar cancer will be diagnosed, and around 1,630 women will die from the disease.
The five-year survival rate for vulvar cancer varies depending on whether the cancer has spread beyond the vulva. The overall survival rate for vulvar cancer is 70%.
As the only National Cancer Institute-designated Comprehensive Cancer Center in Colorado and one of only four in the Rocky Mountain region, the University of Colorado Cancer Center has doctors who provide cutting-edge, patient-centered vulvar cancer care, and researchers focused on diagnostic and therapeutic innovations.
The CU Cancer Center is home to the Women’s Cancer Developmental Therapeutics Program (WCDTP), which seeks to increase the development of novel cancer therapies in vulvar cancer and other gynecologic cancers to decrease cancer-related morbidity and mortality for patients.
Vulvar cancers can be of five types: squamous cell carcinoma, adenocarcinoma, melanoma, sarcoma, and basal cell carcinoma.
Vulvar cancer has multiple risk factors: behaviors or conditions that increase a person’s chances of getting a disease such as cancer. Risk factors for vulvar cancer include:
Vulvar cancer can usually be treated successfully if it is diagnosed before the cancer has spread to distant parts of the body.
Symptoms of vulvar cancer include:
Based on a patient’s symptoms and after an initial physical examination, a doctor may order certain tests to determine whether the patient has vulvar cancer. Though testing procedures can vary based on the type of vulvar cancer the doctor is looking for, common tests for vulvar cancer include:
Biopsy: During a biopsy, a doctor extracts a sample of tissue from the vulva. This is sent to a laboratory for analysis by a pathologist to determine whether the cells in the sample are cancerous.
Magnetic resonance imaging (MRI): An MRI uses radio waves and magnetic fields to produce detailed images of the body.
Computed tomography (CT or CAT) scan: A CT scan uses X-rays to take detailed images of the body and can help determine if cancer has spread to other organs or come back after treatment.
Positron emission tomography (PET) scan: A slightly radioactive form of sugar is injected into the blood, where it is taken in by cells in the body. Since cancer cells grow faster than normal cells, they take in larger amounts of the sugar. Doctors use PET scans to look for possible areas of cancer spread, and to determine if suspicious areas seen in other imaging tests are cancer or not.
After diagnosing the presence of vulvar cancer, the doctor will identify the stage of the disease. The stage is determined by several factors, including where exactly the disease formed, how extensive it is, and whether and how much it has spread.
Many of the same tests used to diagnose vulvar cancer can also be used to help determine the stage, including biopsies, X-rays, CT/CAT scans, and PET scans.
Doctors typically use the TNM system to determine the stage of vulvar cancer. The TNM system assesses the size and extent of the tumor (T) and whether it has ulcerated; whether the cancer has spread to nearby lymph nodes (N); and the presence and extent of metastasis (M) to distant lymph nodes, bones, and organs.
After the TNM assessment, the doctor will assign an overall stage number from I to IV, which can be further broken down based on the size of the original tumor and the extent to which the cancer has spread. In general, the lower the stage the better the prognosis and treatment options.
The treatment for vulvar cancer is customized to each patient and depends on the stage at which the patient is diagnosed, and the patient’s general health.
Vulvar cancer care teams may include multiple health care specialists, including primary care providers, gynecologists, gynecologic oncologists, medical oncologists, hematologists, and radiation oncologists, as well as nurse practitioners, physician assistants, nurses, psychologists, social workers, and rehabilitation specialists. CU Cancer Center doctors offer specialized care for patients with vulvar cancer.
Treatments for vulvar cancer include surgery, radiation therapy, and chemotherapy. Patients may receive one or more of these treatments in combination. The vulvar pre-cancer known as vulvar intraepithelial neoplasia (VIN) may be treated topically. Some patients may also be eligible to participate in clinical trials — doctor-led research studies of new or experimental procedures or treatments.
Surgery is the primary treatment for vulvar cancer. The two main types of surgery for this cancer are excision, which removes the cancer along with a margin of healthy skin around it, or vulvectomy — surgery to remove all or part of the vulva.
Radiation therapy uses high-powered energy to kill cancer cells. A doctor who specializes in radiation therapy to treat cancer is a radiation oncologist. The primary type of radiation therapy used to treat vulvar cancer is external beam radiation, which uses a machine located outside the body to focus a beam of X-rays on the area with the cancer. In vulvar cancer, radiation is most often used in combination with chemotherapy.
Chemotherapy uses drugs to kill rapidly growing cancer cells. Drugs are either injected into a vein or taken orally. The chemotherapy drug most often used to treat vulvar cancer is cisplatin. In vulvar cancer, chemotherapy is often combined with radiation therapy.
Information reviewed by Saketh Guntupalli, MD in February 2024.